Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II.
作者信息
Baldessarini Ross J, Lau Wai K, Sim Jordan, Sum Min Y, Sim Kang
机构信息
International Consortium for Research on Psychotic and Mood Disorders, Mailman Research Center, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts; Research Department and Department of General Psychiatry, Institute of Mental Health, Singapore.
出版信息
Int J Neuropsychopharmacol. 2017 Mar 1;20(3):281-284. doi: 10.1093/ijnp/pyw092.
Abstract
摘要
相似文献
1
Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II.
Int J Neuropsychopharmacol. 2017 Mar 1;20(3):281-284. doi: 10.1093/ijnp/pyw092.
2
The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
Int J Neuropsychopharmacol. 2009 Mar;12(2):181-9. doi: 10.1017/S1461145708009139. Epub 2008 Jul 29.
3
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
JAMA. 2007 Apr 18;297(15):1683-96. doi: 10.1001/jama.297.15.1683.
4
Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
J Affect Disord. 2005 Apr;85(3):245-58. doi: 10.1016/j.jad.2004.12.004.
5
Suicide rates in short-term randomized controlled trials of newer antidepressants.
J Clin Psychopharmacol. 2006 Apr;26(2):203-7. doi: 10.1097/01.jcp.0000203198.11453.95.
6
Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder.
Int J Neuropsychopharmacol. 2015 Sep 13;19(3):pyv107. doi: 10.1093/ijnp/pyv107.
7
Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
J Affect Disord. 2006 Aug;94(1-3):105-10. doi: 10.1016/j.jad.2006.04.002. Epub 2006 Jun 12.
8
Antidepressants and suicidal behavior in bipolar disorder.
Bipolar Disord. 2006 Oct;8(5 Pt 2):596-617. doi: 10.1111/j.1399-5618.2006.00348.x.
9
Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder.
Psychother Psychosom. 2016;85(3):171-9. doi: 10.1159/000442293. Epub 2016 Apr 5.
10
Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.
Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):329-43. doi: 10.1007/s00406-006-0650-x. Epub 2006 Jun 16.
引用本文的文献
1
A Randomized Clinical Trial Comparing Two Treatment Strategies, Evaluating the Meaningfulness of HAM-D Rating Scale in Patients With Major Depressive Disorder.
Front Psychiatry. 2022 May 27;13:873693. doi: 10.3389/fpsyt.2022.873693. eCollection 2022.
2
Music Therapy for Depression Enhanced With Listening Homework and Slow Paced Breathing: A Randomised Controlled Trial.
Front Psychol. 2021 Feb 16;12:613821. doi: 10.3389/fpsyg.2021.613821. eCollection 2021.
3
Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates?
Eur J Public Health. 2021 Apr 24;31(2):291-297. doi: 10.1093/eurpub/ckaa204.
4
Implementing Mobile HRV Biofeedback as Adjunctive Therapy During Inpatient Psychiatric Rehabilitation Facilitates Recovery of Depressive Symptoms and Enhances Autonomic Functioning Short-Term: A 1-Year Pre-Post-intervention Follow-Up Pilot Study.
Front Neurosci. 2020 Jul 21;14:738. doi: 10.3389/fnins.2020.00738. eCollection 2020.
5
Antidepressant Use During Acute Inpatient Care Is Associated With an Increased Risk of Psychiatric Rehospitalisation Over a 12-Month Follow-Up After Discharge.
Front Psychiatry. 2019 Feb 22;10:79. doi: 10.3389/fpsyt.2019.00079. eCollection 2019.
6
Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!
Front Psychiatry. 2018 Oct 17;9:517. doi: 10.3389/fpsyt.2018.00517. eCollection 2018.
7
Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.
Int J Neuropsychopharmacol. 2018 Sep 1;21(9):814-821. doi: 10.1093/ijnp/pyy048.
8
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).
Int J Neuropsychopharmacol. 2018 Jun 1;21(6):539-549. doi: 10.1093/ijnp/pyy009.
9
Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants' Efficacy and Harm.
Front Psychiatry. 2017 Dec 7;8:275. doi: 10.3389/fpsyt.2017.00275. eCollection 2017.
本文引用的文献
1
Suicidal Risks in Report of Reports of Long-Term Treatment Trials for Major Depressive Disorder.
Int J Neuropsychopharmacol. 2017 Mar 1;20(3):279-280. doi: 10.1093/ijnp/pyw084.
2
Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder.
Int J Neuropsychopharmacol. 2015 Sep 13;19(3):pyv107. doi: 10.1093/ijnp/pyv107.
3
Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials.
Int J Neuropsychopharmacol. 2015 Jul 7;19(2):pyv076. doi: 10.1093/ijnp/pyv076.
4
Duration of initial antidepressant treatment and subsequent relapse of major depression.
J Clin Psychopharmacol. 2015 Feb;35(1):75-6. doi: 10.1097/JCP.0000000000000263.
5
Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial.
J Clin Psychiatry. 2013 Feb;74(2):158-66. doi: 10.4088/JCP.12m07974.
6
A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder.
J Psychopharmacol. 2012 Nov;26(11):1408-16. doi: 10.1177/0269881112441866. Epub 2012 Apr 9.
7
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Depress Anxiety. 2010 Oct;27(10):964-76. doi: 10.1002/da.20740.
8
Illness risk following rapid versus gradual discontinuation of antidepressants.
Am J Psychiatry. 2010 Aug;167(8):934-41. doi: 10.1176/appi.ajp.2010.09060880. Epub 2010 May 17.
9
Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study.
Int J Clin Pract. 2010 May;64(6):719-26. doi: 10.1111/j.1742-1241.2010.02374.x. Epub 2010 Mar 23.
10
Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
J ECT. 2010 Jun;26(2):104-10. doi: 10.1097/YCT.0b013e3181c189f7.
Zotero 插件